- Home
- SCLX vs SORA Comparison
SCLX vs SORA Comparison
Compare SCLX & SORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- SORA
- Stock Information
- Founded
- SCLX 2011
- SORA 2001
- Country
- SCLX United States
- SORA Hong Kong
- Employees
- SCLX N/A
- SORA N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- SORA Other Specialty Stores
- Sector
- SCLX Health Care
- SORA Industrials
- Exchange
- SCLX Nasdaq
- SORA Nasdaq
- Market Cap
- SCLX 139.3M
- SORA 131.0M
- IPO Year
- SCLX N/A
- SORA 2025
- Fundamental
- Price
- SCLX $15.30
- SORA $3.84
- Analyst Decision
- SCLX Hold
- SORA
- Analyst Count
- SCLX 1
- SORA 0
- Target Price
- SCLX N/A
- SORA N/A
- AVG Volume (30 Days)
- SCLX 140.1K
- SORA 54.5K
- Earning Date
- SCLX 08-13-2025
- SORA 01-01-0001
- Dividend Yield
- SCLX N/A
- SORA N/A
- EPS Growth
- SCLX N/A
- SORA N/A
- EPS
- SCLX N/A
- SORA N/A
- Revenue
- SCLX $40,360,000.00
- SORA $17,619,363.00
- Revenue This Year
- SCLX $89.26
- SORA N/A
- Revenue Next Year
- SCLX $203.95
- SORA N/A
- P/E Ratio
- SCLX N/A
- SORA N/A
- Revenue Growth
- SCLX N/A
- SORA N/A
- 52 Week Low
- SCLX $3.60
- SORA $1.80
- 52 Week High
- SCLX $34.27
- SORA $14.15
- Technical
- Relative Strength Index (RSI)
- SCLX 42.42
- SORA N/A
- Support Level
- SCLX $17.28
- SORA N/A
- Resistance Level
- SCLX $19.56
- SORA N/A
- Average True Range (ATR)
- SCLX 1.97
- SORA 0.00
- MACD
- SCLX -0.02
- SORA 0.00
- Stochastic Oscillator
- SCLX 3.68
- SORA 0.00
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About SORA Top Win International Limited Ordinary Shares
AsiaStrategy is a wholesaler engaged in trading, distribution, and retail of luxury watches of international brands. The Group sources its luxury watches from Europe, Singapore, Japan, and Hong Kong, then sells the goods to retail sellers and other distributors in the watch industry.